
浏览全部资源
扫码关注微信
430074 武汉,武汉市第三医院消化内科
[姜红梅,E-mail:jianghmzb@163.com JIANG Hongmei, E-mail: jianghmzb@163.com
收稿:2023-11-28,
修回:2024-05-16,
纸质出版:2024-10-15
移动端阅览
徐明星, 李子银, 姜红梅. 麦冬皂苷B调节Rho A/ROCK1信号通路对胃荷瘤大鼠肿瘤生长的抑制作用[J]. 陆军军医大学学报, 2024,46(19):2180-2187.
Mingxing XU, Ziyin LI, Hongmei JIANG. Inhibitory effect of ophiopogonin B on tumor growth in gastric tumor-bearing rats by regulating Rho A/ROCK1 signaling pathway[J]. Journal of Army Medical University, 2024, 46(19): 2180-2187.
徐明星, 李子银, 姜红梅. 麦冬皂苷B调节Rho A/ROCK1信号通路对胃荷瘤大鼠肿瘤生长的抑制作用[J]. 陆军军医大学学报, 2024,46(19):2180-2187. DOI: 10.16016/j.2097-0927.202311142.
Mingxing XU, Ziyin LI, Hongmei JIANG. Inhibitory effect of ophiopogonin B on tumor growth in gastric tumor-bearing rats by regulating Rho A/ROCK1 signaling pathway[J]. Journal of Army Medical University, 2024, 46(19): 2180-2187. DOI: 10.16016/j.2097-0927.202311142.
目的
2
探讨麦冬皂苷B(ophiopogonin B,OP-B)对胃荷瘤大鼠肿瘤生长的影响及其作用机制。
方法
2
将66只体质量为180~200 g的6周龄SPF级SD大鼠(雌雄各半)按随机数字表法分为模型组,OP-B低、中、高剂量组,激活剂组,每组10只。采用原位移植Walker-256肿瘤组织建立胃荷瘤模型,OP-B低、中、高剂量组大鼠分别灌胃17.5、35、70 mg/kg的OP-B并腹腔注射等量生理盐水,激活剂组灌胃70 mg/kg的OP-B并腹腔注射1 mg/kg的Rho A/ROCK1信号通路激活剂溶血磷脂酸(lysophosphatidic acid,LPA),模型组灌胃和腹腔注射等量的生理盐水;记录移植瘤质量及体积,计算抑瘤率;苏木精-伊红(hematoxylin-eosin,HE)染色观察肿瘤组织形态;原位末端转移酶标记技术(TdT-mediated dUTP-biotin nick end labeling,TUNEL)染色检测肿瘤组织细胞凋亡;免疫组织化学染色检测肿瘤组织细胞核增殖抗原67(proliferating cell nuclear antigen,Ki-67)、切割型半胱氨酸天冬氨酸蛋白水解酶-3 (cleaved cysteinyl aspartate specific proteinase-3,Cleaved Caspase-3)表达;实时荧光定量聚合酶链式反应(real-time quantitative polymerase chain reaction,RT-qPCR)法检测Ras同源基因家族蛋白A(Ras homologous gene family member A,Rho A)、Rho相关卷曲螺旋蛋白激酶1(Rho-associated coiled-coil forming protein kinase1,ROCK1)的表达;Western blot检测Rho A、ROCK1蛋白表达。
结果
2
与模型组比较,OP-B低、中、高剂量组肿瘤质量和体积、Ki-67阳性率及Rho A、ROCK1 mRNA和蛋白表达显著降低,抑瘤率、肿瘤细胞凋亡率、Cleaved Caspase-3阳性率显著升高(
P
<0.05);与OP-B高剂量组比较,激活剂组肿瘤质量和体积、Ki-67阳性率及Rho A、ROCK1 mRNA和蛋白表达显著升高,抑瘤率、肿瘤细胞凋亡率、Cleaved Caspase-3阳性率显著降低(
P
<0.05)。
结论
2
OP-B可能通过抑制Rho A/ROCK1信号通路的激活,抑制胃荷瘤大鼠肿瘤生长。
Objective
2
To investigate the effect of ophiopogonin B (OP-B) on tumor growth in gastric tumor-bearing rats and its underlying mechanism.
Methods
2
Sixty-six SPF SD rats (half male and female
6 weeks old
180~200 g) were randomly divided into model group
low-
medium- and high-dose OP-B groups
and activator group
with 10 rats in each group. The gastric tumor-bearing model was established by orthotopic transplantation of Walker-256 tumor tissue. The rats in the 3 doses groups were given 17.5
35 and 70 mg/kg OP-B
respectively
by gavage and intraperitoneal injection of the same amount of normal saline
and the rats in the activator group were intragastrically administered with 70 mg/kg OP-B and intraperitoneally injected with 1 mg/kg Rho A/ROCK1 signaling pathway activator
lysophosphatidic acid (LPA). The weight and volume of transplanted tumor were recorded to calculate the tumor inhibitory rate. The morphology of tumor tissue was observed with HE staining. The apoptosis of tumor cells were detected by TdT-mediated dUTP-biotin nick end labeling (TUNEL) staining. The expression of proliferating cell nuclear antigen 67 (Ki-67) and cleavage cysteine aspartic acid proteolytic enzyme-3 (Cleaved Caspase-3) in tumor tissues were detected by immunohistochemical staining. RT-qPCR and Western blotting were utilized to measure the expression of Ras homologous gene family member A (Rho A) and Rho-associated coiled-coil forming protein kinase1(ROCK1) at mRNA and protein levels.
Results
2
Compared with the model group
the tumor weight and volume
mRNA and protein levels of Ki-67
Rho A and ROCK1 were significantly decreased
and the tumor inhibitory rate
tumor cell apoptotic rate and Cleaved Caspase-3 protein level were obviously increased in the low-
medium- and high-dose OP-B groups (
P
<
0.05). The activator group had heavier tumor weight and larger volume
increased mRNA and protein expression levels of Ki-67
Rho A and ROCK1
and lower tumor inhibitory rate and apoptotic rate and reduced Cleaved Caspase-3 expression when compared with the high-dose OP-B group (
P
<
0.05).
Conclusion
2
OP-B may suppress the tumor growth of gastric tumor-bearing rats by inhibiting the activation of Rho A/ROCK1 signaling pathway.
RÖCKEN C. Predictive biomarkers in gastric cancer[J]. J Cancer Res Clin Oncol, 2023, 149(1): 467-481. DOI: 10.1007/s00432-022-04408-0.
ALSINA M, ARRAZUBI V, DIEZ M, et al . Current developments in gastric cancer: from molecular profiling to treatment strategy[J ] . Nat Rev Gastroenterol Hepatol, 2023, 20(3): 155-170. DOI: 10.1038/s41575-022-00703-w.
CHENG Z Y, LI Z H, GU L, et al . Ophiopogonin B alleviates cisplatin resistance of lung cancer cells by inducing Caspase-1/GSDMD dependent pyroptosis[J ] . J Cancer, 2022, 13(2): 715-727. DOI: 10.7150/jca.66432.
LI L Q, GAO Q, WANG J, et al . Induction of ferroptosis by ophiopogonin-B through regulating the gene signature AURKA in NSCLC[J ] . Front Oncol, 2022, 12: 833814. DOI: 10.3389/fonc.2022.833814..
DONG W H, DONG Q, DING H R. Ophiopogonin B induces reactive oxygen species-dependent apoptosis through the Hippo pathway in nasopharyngeal carcinoma[J]. Mol Med Rep, 2021, 24(1): 534. DOI: 10.3892/mmr.2021.12173.
ZHANG L Y, LI C L, ZHANG Y Z, et al . Ophiopogonin B induces gastric cancer cell death by blocking the GPX4/xCT-dependent ferroptosis pathway[J ] . Oncol Lett, 2022, 23(3): 104. DOI: 10.3892/ol.2022.13224.
LIU D, XIA A D, WU L P, et al . IGF 2 BP 2 promotes gastric cancer progression by regulating the IGF1R-Rho A-ROCK signaling pathway[J ] . Cell Signal, 2022, 94: 110313. DOI: 10.1016/j.cellsig.2022.110313..
廖山婴, 刘超, 王蓓蓓, 等. Rho A/ROCK1信号通路在胃癌中的表达及其与胃癌生物学行为的关系[J]. 胃肠病学和肝病学杂志, 2017, 26(3): 251-255. DOI: 10.3969/j.issn.1006-5709.2017.03.003.
LIAO S Y, LIU C, WANG B B, et al . Relationship between expression of Rho A/ROCK1 signaling pathway and biologic be-haviors of gastric carcinoma[J ] . Chin J Gastroenterol Hepatol, 2017, 26(3): 251-255. DOI: 10.3969/j.issn.1006-5709.2017.03.003.
谭静, 林亚平, 赵欢, 等. 艾灸对胃荷瘤大鼠瘤体内Th1、Th2类细胞因子表达的影响[J]. 免疫学杂志, 2019, 35(12): 1061-1066. DOI: 10.13431/j.cnki.immunol.j.20190167.
TAN J, LIN Y P, ZHAO H, et al . Effects of moxibustion on the expression of Th1 and Th2 cytokines in gastric tumor-bearing rats[J ] . Immunol J, 2019, 35(12): 1061-1066. DOI: 10.13431/j.cnki.immunol.j.20190167.
LI M W, ZHANG L M, LIU X Y, et al . Inhibition of Rho/ROCK signaling pathway participates in the cardiac protection of exercise training in spontaneously hypertensive rats[J ] . Sci Rep, 2022, 12(1): 17903. DOI: 10.1038/s41598-022-22191-3.
CONTI C B, AGNESI S, SCARAVAGLIO M, et al . Early gastric cancer: update on prevention, diagnosis and treatment[J ] . Int J Environ Res Public Health, 2023, 20(3): 2149. DOI: 10.3390/ijerph20032149.
ARAÚJO D, RIBEIRO E, AMORIM I, et al . Repurposed drugs in gastric cancer[J ] . Molecules, 2022, 28(1): 319. DOI: 10.3390/molecules28010319.
何冰倩, 周小杰, 史冬玲, 等. 麦冬皂苷B抗肿瘤作用机制研究进展[J]. 中华中医药学刊, 2018, 36(12): 2911-2914. DOI: 10.13193/j.issn.1673-7717.2018.12.022.
HE B Q, ZHOU X J, SHI D L, et al . Progress on anti-tumor effects and mechanisms of ophiopogonin B[J ] . Chin Arch Tradit Chin Med, 2018, 36(12): 2911-2914. DOI: 10.13193/j.issn.1673-7717.2018.12.022.
ZHANG S P, LI H X, LI L Q, et al . Ophiopogonin B inhibits migration and invasion in non-small cell lung cancer cells through enhancing the interaction between Axin and β-catenin[J ] . J Cancer, 2021, 12(20): 6274-6284. DOI: 10.7150/jca.60066.
YUAN F, GAO Q, TANG H L, et al . Ophiopogonin-B targets PTP1B to inhibit the malignant progression of hepatocellular carcinoma by regulating the PI3K/AKT and AMPK signaling pathways[J ] . Mol Med Rep, 2022, 25(4): 122. DOI: 10.3892/mmr.2022.12638.
CHOI E K, KIM J G, KIM H J, et al . Regulation of Rho A GTPase and novel target proteins for ROCK[J ] . Small GTPases, 2020, 11(2): 95-102. DOI: 10.1080/21541248.2017.1364831.
MAO Y F, JIANG X Y, GUO P, et al . ZXDC enhances cervical cancer metastasis through IGF 2 BP 3 -mediated activation of Rho A / ROCK signaling[J ] . iScience, 2023, 26(8): 107447. DOI: 10.1016/j.isci.2023.107447..
YANG Y T, LI L Y, HE H, et al . Numb inhibits migration and promotes proliferation of colon cancer cells via Rho A/ROCK1 signaling pathway repression[J ] . Exp Cell Res, 2022, 411(2): 113004. DOI: 10.1016/j.yexcr.2021.113004.
ZHANG Z, NONG L, CHEN M L, et al . Baicalein suppresses vasculogenic mimicry through inhibiting Rho A/ROCK1 expression in lung cancer A549 cell line[J ] . Acta Biochim Biophys Sin, 2020, 52(9): 1007-1015. DOI: 10.1093/abbs/gmaa075.
梁美兰, 廖晓宏, 张恒斌, 等. Nesfatin-1通过Rho A/ROCK1-1通路促进人胃癌AGS细胞的增殖[J]. 胃肠病学和肝病学杂志, 2021, 30(8): 900-903. DOI: 10.3969/j.issn.1006-5709.2021.08.010.
LIANG M L, LIAO X H, ZHANG H B, et al . Nesfatin-1 promotes proliferation of gastric cancer cell line AGS through Rho A/ROCK1-1 signaling pathway[J ] . Chin J Gastroenterol Hepatol, 2021, 30(8): 900-903. DOI: 10.3969/j.issn.1006-5709.2021.08.010.
廖山婴, 刘超, 王蓓蓓, 等. 复方斑蝥胶囊调控Rho A/ROCK1信号通路抑制MNNG诱导的大鼠胃癌发生[J]. 中国中西医结合杂志, 2019, 39(6): 728-732. DOI: 10.7661/j.cjim.20181031.321.
LIAO S Y, LIU C, WANG B B, et al . Fufang Banmao capsule inhibited N-methyl-N-nitro-N-nitrosoguanidine induced gastric carcinoma in rats by regulating Rho A/ROCK1 signaling pathway[J ] . Ch in J Integr Tradit West Med, 2019, 39(6): 728-732. DOI: 10.7661/j.cjim.20181031.321.
0
浏览量
144
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621